65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79725D0227
- Awardee
-
Ucb, Inc. UEI F3N9Q9TY2BC9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 6
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 22% complete
- IDV ceiling
- $1,113,226,759.30
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Ucb, Inc. (doing business as UCB Pharma, Inc.) under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on September 15, 2025, with a ceiling value of $1,113,226,759.30 and ultimate completion date of September 14, 2030. This is a multiple-award schedule vehicle enabling the Department of Veterans Affairs, through Veterans Integrated Service Network 12, to place orders against pre-negotiated pricing for pharmaceutical products.
The contract covers injectable and oral neurological and immunological prescription medications including Zilbrysq, Fintepla, Kygevvi, Cimzia, Nayzilam, Neupro, Vimpat, Briviact, and Keppra. Place of performance is Pittsburgh, Pennsylvania. All ordering activity carries firm fixed-price pricing with no set-aside designation.
Recent delivery orders under this schedule include five orders from Veterans Integrated Service Network 5 for Zilbrysq 32.4 mg, each valued at $31,040.96 and issued between March 4, 2026, and August 6, 2026, with completion dates ranging from March through September 2026. Veterans Integrated Service Network 20 issued a $371,175.06 delivery order on October 25, 2025, for Zilbrysq 32.4MG/0.81ML injection solution with 2026 price increase adjustment, scheduled for completion by October 24, 2026.
UCB Pharma also holds a related single-award Blanket Purchase Agreement from the National Acquisition Center, valued at $3,836,045.45 and awarded October 31, 2025, for Fintepla, Zilbrysq, and Kygevvi, with completion scheduled for October 30, 2026. The FSS-61-IB schedule establishes pre-negotiated pricing to support VA acquisition of essential prescription medications nationwide.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Injectable drug for a veteran | Veterans Integrated Service Network 5 (VHA) | $31,041 | |
| Zilbrysq 32.4 MG | Veterans Integrated Service Network 5 (VHA) | $31,041 | |
| Zilbrysq 32.4 MG | Veterans Integrated Service Network 5 (VHA) | $31,041 | |
| Zilbrysq 32.4 MG | Veterans Integrated Service Network 5 (VHA) | $31,041 | |
| Zilbrysq 32.4 MG | Veterans Integrated Service Network 5 (VHA) | $31,041 | |
| Zilbrysq 32.4MG/0.81ML INJ, soln SY. | Veterans Integrated Service Network 20 (VHA) | $371,175 |
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79726A0005 | National Acquisition Center (VA) | $3,836,045 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 12
Quick answers
Who was awarded contract 36F79725D0227?
36F79725D0227 was awarded to Ucb, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2025.
How much is contract 36F79725D0227 worth?
36F79725D0227's own ceiling is $1,113,226,759.
How many orders have been placed under contract 36F79725D0227?
6 orders have been placed under 36F79725D0227, the latest on August 6, 2026.
Who can order from contract 36F79725D0227?
36F79725D0227 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79725D0227 part of a contract vehicle?
Yes. 36F79725D0227 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79725D0227 competed?
The extent of competition for 36F79725D0227 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV